Latest by Sony Salzman

A Review of Late-Stage HIV Antiretroviral Candidates at IDWeek 2017

Highlights of major findings on new antiretroviral therapies, including data on long-acting injectable solutions and new combination treatments packed into a single pill.

By Sony Salzman

A Review of Late-Stage HIV Antiretroviral Candidates at IDWeek 2017

Highlights of major findings on new antiretroviral therapies, including data on long-acting injectable solutions and new combination treatments packed into a single pill.

By Sony Salzman

PrEP Prescriptions Rise Sharply, but Unequally, in New York City

In New York City, the number of people taking PrEP has skyrocketed in recent years -- yet prescriptions are more likely to be written for affluent white men than others, research finds.

By Sony Salzman

Ignorance About PrEP Is Common Among Health Care Providers, Studies Suggest

Several PrEP studies presented at IDWeek focused on the need for better education among clinicians and medical students regarding not only how PrEP works and whom it can benefit but also that it even exists as an HIV prevention option.

By Sony Salzman

HIV Self-Test Helps ID 'Hidden People' With HIV Across the Globe, but Questions Remain

OraQuick use is being scaled up across the globe -- but, as with any new technology, some experts are worried about possible implications of a rollout in Africa, Asia and other less-wealthy regions where HIV is a major public health crisis.

By Sony Salzman

Guidance for Providers Treating HIV-Positive People Displaced by Disasters

In response to Hurricane Harvey, the federal government's AIDS working group has released an updated how-to manual designed for nurses, doctors and community health workers treating displaced people with HIV.

By Sony Salzman

Which Hepatitis C Treatment to Start

The hepatitis C treatment landscape has changed dramatically in a few short years, and the pace of change is expected to continue as even more new drugs are approved. Picking the right treatment for each patient depends on medical history, HCV genotype…

By Sony Salzman

Research in New York Confirms That MSM Will Likely Follow Up After a Positive at-Home HIV Test

Data from New York City's partner services program indicate that men who have sex with men (MSM) who test positive with an in-home testing kit are likely to seek confirmatory testing right away.

By Sony Salzman

Mavyret Approved as Eight-Week HCV Treatment Regimen, Including for Those With Mild Cirrhosis

A combination of glecaprevir and pibrentasvir (Mavyret), has been approved for hepatitis C treatment, for any genotype, with a treatment duration of only eight weeks -- four weeks less than most other current regimens.

By Sony Salzman

Hepatitis C: How Is It Transmitted and Who Should Be Tested?

Hepatitis C (HCV) is one of the more common chronic viral infections in the U.S., thought to affect nearly four million Americans. Here we review how HCV is transmitted and who should be tested.

By Sony Salzman